These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 29444987)

  • 1. Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection.
    Triant VA; Perez J; Regan S; Massaro JM; Meigs JB; Grinspoon SK; D'Agostino RB
    Circulation; 2018 May; 137(21):2203-2214. PubMed ID: 29444987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction models.
    Krikke M; Hoogeveen RC; Hoepelman AI; Visseren FL; Arends JE
    HIV Med; 2016 Apr; 17(4):289-97. PubMed ID: 26268806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Risk Estimation Is Suboptimal in People With HIV.
    Triant VA; Lyass A; Hurley LB; Borowsky LH; Ehrbar RQ; He W; Cheng D; Lo J; Klein DB; Meigs JB; Grinspoon SK; Plutzky J; Silverberg MJ; LaValley M; Massaro JM; D'Agostino RB
    J Am Heart Assoc; 2024 May; 13(10):e029228. PubMed ID: 38761071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
    Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
    JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa.
    Mosepele M; Hemphill LC; Palai T; Nkele I; Bennett K; Lockman S; Triant VA
    PLoS One; 2017; 12(2):e0172897. PubMed ID: 28235058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living With HIV.
    van Zoest RA; Law M; Sabin CA; Vaartjes I; van der Valk M; Arends JE; Reiss P; Wit FW
    J Acquir Immune Defic Syndr; 2019 Aug; 81(5):562-571. PubMed ID: 31045648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative performance of cardiovascular risk prediction models in people living with HIV.
    Tahir IS; Vos AG; Damen JAA; Barth RE; Tempelman HA; Grobbee DE; Scheuermaier K; Venter WDF; Klipstein-Grobusch K
    South Afr J HIV Med; 2022; 23(1):1395. PubMed ID: 36479421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of new scores for atherosclerotic cardiovascular disease using specific medical examination items: the Suita Study.
    Arafa A; Kashima R; Yasui Y; Kawachi H; Matsumoto C; Nosaka S; Teramoto M; Matsuo M; Kokubo Y
    Environ Health Prev Med; 2023; 28():61. PubMed ID: 37899208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Prognostic Implications of Coronary Artery Calcification in Low-Risk Women: A Meta-analysis.
    Kavousi M; Desai CS; Ayers C; Blumenthal RS; Budoff MJ; Mahabadi AA; Ikram MA; van der Lugt A; Hofman A; Erbel R; Khera A; Geisel MH; Jöckel KH; Lehmann N; Hoffmann U; O'Donnell CJ; Massaro JM; Liu K; Möhlenkamp S; Ning H; Franco OH; Greenland P
    JAMA; 2016 Nov; 316(20):2126-2134. PubMed ID: 27846641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular Disease Risk Prediction in the HIV Outpatient Study.
    Thompson-Paul AM; Lichtenstein KA; Armon C; Palella FJ; Skarbinski J; Chmiel JS; Hart R; Wei SC; Loustalot F; Brooks JT; Buchacz K
    Clin Infect Dis; 2016 Dec; 63(11):1508-1516. PubMed ID: 27613562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology/American Heart Association Guidelines With Subsequent Cardiovascular Disease Events.
    Son JS; Choi S; Kim K; Kim SM; Choi D; Lee G; Jeong SM; Park SY; Kim YY; Yun JM; Park SM
    JAMA; 2018 Nov; 320(17):1783-1792. PubMed ID: 30398603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of future cardiovascular events by Framingham, SCORE and asCVD risk scores is less accurate in HIV-positive individuals from the HIV-HEART Study compared with the general population.
    Schulz CA; Mavarani L; Reinsch N; Albayrak-Rena S; Potthoff A; Brockmeyer N; Hower M; Erbel R; Jöckel KH; Schmidt B; Esser S;
    HIV Med; 2021 Sep; 22(8):732-741. PubMed ID: 34028959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons.
    Chew KW; Bhattacharya D; Horwich TB; Yan P; McGinnis KA; Tseng C; Freiberg MS; Currier JS; Butt AA
    J Viral Hepat; 2017 Oct; 24(10):814-822. PubMed ID: 28273386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between change in cardiovascular risk scores and future cardiovascular disease: analyses of data from the Whitehall II longitudinal, prospective cohort study.
    Lindbohm JV; Sipilä PN; Mars N; Knüppel A; Pentti J; Nyberg ST; Frank P; Ahmadi-Abhari S; Brunner EJ; Shipley MJ; Singh-Manoux A; Tabak AG; Batty GD; Kivimäki M
    Lancet Digit Health; 2021 Jul; 3(7):e434-e444. PubMed ID: 34167764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Asgari S; Moosaie F; Orangi M; Sarvghadi F; Khalili D; Azizi F
    J Transl Med; 2021 Jan; 19(1):25. PubMed ID: 33407576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observed versus predicted cardiovascular events and all-cause death in HIV infection: a longitudinal cohort study.
    De Socio GV; Pucci G; Baldelli F; Schillaci G
    BMC Infect Dis; 2017 Jun; 17(1):414. PubMed ID: 28606059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.
    Albarqouni L; Doust JA; Magliano D; Barr EL; Shaw JE; Glasziou PP
    Med J Aust; 2019 Mar; 210(4):161-167. PubMed ID: 30656697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Pooled Cohort Equations for Prediction of Cardiovascular Risk in a Contemporary Prospective Cohort.
    Emdin CA; Khera AV; Natarajan P; Klarin D; Baber U; Mehran R; Rader DJ; Fuster V; Kathiresan S
    Am J Cardiol; 2017 Mar; 119(6):881-885. PubMed ID: 28061997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of Risk Prediction Models for Cardiovascular Events in Black Adults: The Jackson Heart Study Cohort.
    Fox ER; Samdarshi TE; Musani SK; Pencina MJ; Sung JH; Bertoni AG; Xanthakis V; Balfour PC; Shreenivas SS; Covington C; Liebson PR; Sarpong DF; Butler KR; Mosley TH; Rosamond WD; Folsom AR; Herrington DM; Vasan RS; Taylor HA
    JAMA Cardiol; 2016 Apr; 1(1):15-25. PubMed ID: 27437649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P
    Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.